Research & Clinical Trials
Study: Mesothelioma Survival Rates Rise with SMART Protocol
- by Tim Povtak
- Research & Clinical Trials
- Jan 21, 2021
Using accelerated high-dose radiation prior to surgery produced an unprecedented 65.9-month median survival for a cohort of pleural mesothelioma patients who were part of a larger clinical trial at…
Read More
Statins May Give Boost to Mesothelioma Immunotherapy Drugs
- by Tim Povtak
- Research & Clinical Trials
- Jan 7, 2021
Researchers in Europe may have found the key to making immunotherapy drugs such as Opdivo and Keytruda more effective for a larger percentage of patients with malignant pleural mesothelioma.
Read More
Study: Immunotherapy Vaccine for Mesothelioma Still Promising
- by Tim Povtak
- Research & Clinical Trials
- Dec 3, 2020
The ONCOS-102 immunotherapy vaccine continues its move toward future, first-line standard of care treatment for malignant pleural mesothelioma, based upon the latest study follow-up data. When combined with standard…
Read More
Mesothelioma Patient Research Expanding in United Kingdom
- by Tim Povtak
- Research & Clinical Trials
- Nov 30, 2020
The University of Sheffield has launched the Mesothelioma UK Research Centre-Sheffield, the country’s first experience-based program designed to improve the treatment and care of patients diagnosed with this aggressive,…
Read More
Latest T-Cell Clinical Trial Opens for Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- Oct 8, 2020
Memorial Sloan Kettering Cancer Center in New York City has begun recruiting patients with pleural mesothelioma for its latest — and potentially most promising — clinical trial involving T-cell…
Read More
Gene Therapy Clinical Trial for Mesothelioma Moving Forward
- by Tim Povtak
- Research & Clinical Trials
- Sep 23, 2020
A much-anticipated, phase III clinical trial studying the use of gene therapy to combat pleural mesothelioma cancer has made a promising start. Interest is growing in what many believe…
Read More
Mesothelioma Trial to Test Cancer Vaccine with Immunotherapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 14, 2020
A research team at Oslo University Hospital in Norway has opened a mesothelioma clinical trial using the novel UV1 cancer vaccine alongside a promising immunotherapy combination. UV1 is a…
Read More
New Lung Cancer Trial Could Benefit Mesothelioma Patients
- by Sean Marchese
- Research & Clinical Trials
- Aug 19, 2020
Pharmaceutical giant Merck has teamed up with Novocure to test its cornerstone immunotherapy, pembrolizumab (Keytruda), alongside Tumor Treating Fields. The new phase II clinical research trial is focusing on…
Read More
Immunotherapy Combination Extends Mesothelioma Survival
- by Tim Povtak
- Research & Clinical Trials
- Aug 11, 2020
Standard-of-care treatment for unresectable pleural mesothelioma cancer could be changing soon, sparked by a recently completed international study of a novel immunotherapy combination. Patients in the randomized mesothelioma…
Read More
Mesothelioma Clinical Trials Resume After COVID-19 Disruption
- by Sean Marchese
- Research & Clinical Trials
- Aug 10, 2020
When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold. As businesses begin to reopen…
Read More
